Sironax: Novartis Exercises Exclusive Rights to Acquire Global Rights to the Company's Proprietary Brain Delivery Platform
2026-09-16 19:07:05
According to CoinMeta, as reported by Reuters, Novartis (Novartis) has exercised its exclusive right to acquire the global rights to Sironax's proprietary brain delivery platform, a transaction that stems from an agreement reached in July 2025.
Bullish 0
Bearish 0
Source:Internet
This content is for market information only and does not constitute investment advice.